Find out which of the four dimensions is killing your win rate.


BUYER READINESS CHECK

Find out which of the four dimensions is killing your win rate.

4 minutes

A four-minute diagnostic that maps your hardest deal against the four reasons B2B buyers stall, and tells you which one is costing you the close.

14 questions

4 minutes

A four-minute diagnostic that maps your hardest deal against the four reasons B2B buyers stall, and tells you which one is costing you the close.

14 questions

This assessment measures observable behavioral signals across the four buyer readiness dimensions. It does not ask you to predict your own pipeline outcomes. Self-report intent measurement inflates intention-behavior correlation by 58% (Wilson et al., 2024), and any tool that claims to "predict" closing is overclaiming. What this does is identify which dimension is currently blocking momentum on the deal you have in mind, and which specific protocol resolves that gap.

AI-referred buyers expect post-click experiences as easy to use as the LLMs that referred them. 60% of marketers say so (HubSpot State of Marketing 2026). The four-minute check is calibrated for that bar. No quiz funnel. No pre-gating questions. You start, you score, you see your result.

This assessment measures observable behavioral signals across the four buyer readiness dimensions. It does not ask you to predict your own pipeline outcomes. Self-report intent measurement inflates intention-behavior correlation by 58% (Wilson et al., 2024), and any tool that claims to "predict" closing is overclaiming. What this does is identify which dimension is currently blocking momentum on the deal you have in mind, and which specific protocol resolves that gap.

AI-referred buyers expect post-click experiences as easy to use as the LLMs that referred them. 60% of marketers say so (HubSpot State of Marketing 2026). The four-minute check is calibrated for that bar. No quiz funnel. No pre-gating questions. You start, you score, you see your result.

WHAT YOU GET

Understanding with tools to move forward.

Understanding with tools to move forward.

Equipped to succeed.

Your readiness score

A score across four dimensions of buyer readiness, with your weakest dimension flagged and a written interpretation of what's driving it.

Your friction cost

An estimate of what indecision is costing you in revenue this quarter, calibrated to your deal size. You might be surprized.

Your next step

If you want to apply this to your real pipeline, book a 30-minute diagnostic call. If you want to learn more first, read the buyer readiness pillar."

FAQ

Questions we hear most.

Questions we hear most.

Who built this, and why should I trust the methodology?

I did. I am Wilton Blake. Seventeen years inside B2B revenue engines, working in content, sales enablement, and pipeline operations across early-stage startups, growth-stage SaaS, and enterprise platforms managing more than 1,500 franchise brands. I am not a salesperson. That matters here. The four dimensions came out of a question I could not stop asking. I spent years producing content for revenue teams. The demos. The decks. The case studies. The campaigns. I watched the same pattern across every company I worked with. The content was good. The campaigns hit their numbers. Pipeline filled. Then conversion stayed flat. Win rates did not move. Qualified deals died before anyone said no, and nobody could explain why. The marketing team blamed sales. The sales team blamed leads. The CRO blamed the market. Everyone had a theory. None of them survived contact with the data. What I noticed, sitting one layer above the deal, was that the content was not the problem. The buyer was not ready. The collateral was being asked to do work it could not do, because the buyer had not yet decided they had a problem worth solving. Or could not articulate what success looked like. Or did not have the room internally to move. None of that was a content problem. None of it was a sales problem either, in the way sales teams talk about sales problems. It was a readiness problem, and nobody was diagnosing it. I was not trained on a sales framework. I came to this from the outside. That is part of why DecisionScope looks different from BANT or MEDDIC or Challenger. Those are seller-side qualification tools written by people who carried a quota. They tell a rep how to advance a buyer who is already in motion. They have nothing to say about the buyer who is not. I built the dimensions to measure that earlier moment. Problem Conviction. Evaluation Clarity. Outcome Confidence. Organizational Readiness. Each one names a thing that has to be true before a buyer will move. If any one of them is missing, the deal stalls. You can usually feel which one. The diagnostic just makes you say it out loud. The research validates what I was already seeing in the field. Dixon and McKenna (Harvard Business Review, 2022) put a number on the pattern: 56 percent of inaction losses come from buyer indecision, not status quo preference. Eighty-seven percent of opportunities contain moderate-to-high indecision. Ebsta and Pavilion (2024) confirmed it independently, finding 61 percent of lost deals attributed to buyer indecision. None of that generated the dimensions. It gave the pattern a name. The dimensions themselves stand on older and broader research. Indecision decomposes cleanly into three uncertainty types in the academic literature: valuation, information, and outcome (Germeijs and De Boeck, 2003). Status quo bias, formally identified in Samuelson and Zeckhauser (1988) and replicated across health-plan and retirement decisions, has thirteen documented countermeasures across cognitive, rational, and psychological dimensions (Godefroid et al., 2022). Loss aversion, the endowment effect, and status quo bias share an underlying asymmetry of value (Kahneman, Knetsch, and Thaler, 1991). When buyers cannot verify outcomes, trust does the work that evidence cannot (Siegrist, Gutscher, and Earle, 2005). That is well established in the procurement literature. The Organizational Readiness dimension exists because buying is a multi-stakeholder process, not an individual transaction. Webster and Wind's buying center model from 1972 is still cited in current research. The current data is harder. Forrester's 2026 figure puts the average B2B buying group at thirteen internal stakeholders and nine external influencers. Gartner has shown that 74 percent of these groups demonstrate unhealthy conflict during decisions, and that groups achieving consensus are 2.5 times more likely to report a high-quality deal. Win rates peak at four to five stakeholders and decline past six (Brontén and Cabrera, Journal of Systems Thinking, 2025). None of that is mine. I built the dimension on it. What I added was the diagnostic. The four dimensions are mine. The protocols that resolve each one are mine. The check measures observable behavior, not seller optimism. Every question is calibrated against what the buyer said or did, not what you hope they meant. Same answers, same score, every time. No AI guessing at your situation. One last thing. The most expensive misread in B2B is treating an indecisive buyer like a hesitant one and applying pressure. Dixon and McKenna's data shows pressure tactics on indecisive buyers degrade win rates by 84 percent. Top performers are 364 percent less likely than average performers to lose deals to indecision, because they read the dimension and apply the right move (Ebsta and Pavilion, 2024). That is what your content cannot do for you. That is what your CRM scoring cannot tell you. That is what the diagnostic does, in four minutes.

How long does this actually take?

Four minutes. Twelve questions. The clock starts when you answer the first one and stops when your score loads. There is no pre-form, no email gate, no "tell us about your company" wall before you can begin. You answer twelve questions about a single deal you have in mind, and you see your result. If you finish in three minutes, you rushed it. If it took you eight, you were thinking carefully about a real deal. Either is fine.

Do I need any data or research before I start?

No. Pick one deal that is currently in your pipeline and stalled, or one that just closed lost. Have that deal in mind. That is all you need. The questions ask about observable behavior: what the buyer has said, what they have done, who has shown up to which meetings. You are not estimating probabilities or predicting close dates. You are reporting what already happened. Anyone who has worked the deal can answer.

What happens to my email address?

You see your score before you give us your email. The score loads, the dimension breakdown loads, the friction cost loads. All of it. If you want the written interpretation sent to you, you give us an email. If you want to book the 30-minute diagnostic call, you give us an email. If you want to leave with the screen result and never hear from us, you can do that. We do not sell, rent, or share the list. There is no nurture sequence designed to wear you down.

What if the deal I have in mind already closed lost?

That is one of the best uses of the check. Run it on a recent loss. Most loss reviews stop at "they went with a competitor" or "budget got cut." Those are stories the buyer tells the seller to end the conversation. They are almost never the real reason. The four dimensions tell you which one of them actually broke. You will usually find the deal was dead two months before you marked it closed lost, and you will see exactly which signal you missed.

I have several deals stalled. Which one should I think about?

Pick the one that is keeping you up at night. The one where you cannot quite explain why it stopped moving. The deals that are obviously dead do not need this. The deals that are obviously closing do not need this. The diagnostic earns its value on the deal you keep telling yourself is "still active" when you know something is wrong. That is the deal to bring. You can run the check more than once if you want to compare two deals.

How is this different from BANT, MEDDIC, or Challenger?

Those are seller-side frameworks. They tell you what information to gather and what to push the buyer toward. They are useful when the buyer has decided they have a problem worth solving and is moving through evaluation. DecisionScope measures something earlier and different: whether the buyer has actually decided. The JOLT Effect research (Dixon and McKenna, Harvard Business Review, 2022), based on 2.5 million sales calls, found that 40 to 60 percent of lost B2B deals are not lost to competitors. They are lost to indecision. The buyer simply does not pull the trigger. BANT and MEDDIC do not catch that, because they assume the buyer is already in motion. The four readiness dimensions tell you whether they are. You can run BANT or MEDDIC alongside DecisionScope. They answer different questions.

Is the score comparable across teams, deal sizes, or industries?

Yes, with one caveat. The dimensions and the scoring are constant. A "low Evaluation Clarity" reading means the same thing on a $20,000 deal as it does on a $2,000,000 deal: the buyer cannot articulate the criteria they are using to choose. The friction cost is the part that flexes. We calibrate the dollar estimate to the deal size you enter. So a low Outcome Confidence reading on a $50,000 deal and a $500,000 deal will surface the same dimension, but the cost of letting it sit will be different. If you run the check across a sales team, the dimension distribution is comparable. The cost numbers are not.

Will this tell me whether the deal is going to close?

No, and that is on purpose. Any tool that claims to predict closing based on the seller's read of the buyer is overclaiming. Sellers are systematically optimistic about their own deals. So are the tools built to flatter them. What this does is identify which of the four dimensions is blocking momentum, and tell you which protocol resolves that gap. Whether you use the protocol is your call. Whether the deal closes is a function of what you do next.

What does the paid diagnostic include that this does not?

The free check looks at one deal. The $7,500 paid diagnostic looks at your pipeline. We pull twenty to forty deals from your CRM, score each one against the four dimensions, and produce a portfolio view: where the friction is concentrated, which reps are running into the same wall, which dimension is structurally weak across the team, and which deals are recoverable this quarter versus structurally dead. You get the dollar exposure across the whole pipeline, not one deal. You get a written debrief, a 90-minute walkthrough with your team, and a prioritized protocol sequence to apply in the next thirty days. The free check tells you what is wrong with one deal. The paid diagnostic tells you what is wrong with how your team is selling.

Can I run this for a deal where I am the buyer, not the seller?

Yes, and it is illuminating. Most buyers do not realize how many of the four dimensions are unresolved on their own side until they see the dimensions named. If you are evaluating a vendor right now and the process feels stuck, run the check from the buyer seat. You will usually find that one of the four is unresolved internally, and that is what is keeping you from deciding. The seller cannot fix it for you.